Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2024)
Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Score Price Valuation Financials Forecast Earnings & Revenue Dividends Ownership

Ticker	Company	Country	Market Cap	Shares	Institutional %	Insider %	Net Insider (L12M)	Net Insider (L3M)
AVDL	AVADEL PHARMACEUTICALS PLC	Ireland	$1.59B	96,118,523	58.37%	13.53%	Net Selling
PRPH	PROPHASE LABS INC	United States	$96.35M	19,078,529	8.85%	54.08%
ASND	ASCENDIS PHARMA A	Denmark	$7.77B	58,224,419	100.00%	0.00%
GKOS	GLAUKOS CORP	United States	$5.56B	50,367,507	63.66%	36.34%	Net Selling	Net Selling
DOMH	DOMINARI HOLDINGS INC	United States	$12.70M	5,995,065	7.25%	92.75%	Net Buying	Net Buying
SENS	SENSEONICS HOLDINGS INC	United States	$247.29M	530,668,435	12.39%	37.51%	Net Selling	Net Buying
AZTA	AZENTA INC	United States	$2.78B	53,918,934	82.78%	17.22%	Net Selling	Net Selling
MNPR	MONOPAR THERAPEUTICS	United States	$11.75M	17,484,175	1.40%	98.60%	Net Selling	Net Selling
IMUX	IMMUNIC INC	Germany	$114.40M	90,079,016	16.44%	17.15%	Net Buying	Net Buying
MNMD	MIND MEDICINE (MINDMED) INC	Canada	$665.54M	71,872,422	6.78%	60.95%	Net Selling	Net Selling
SXTC	CHINA SXT PHARMACEUTICALS INC	China	$771.52k	727,851	1.26%	0.00%
DAWN	DAY ONE BIOPHARMACEUTICALS INC	United States	$1.40B	87,389,859	54.75%	45.25%	Net Buying	Net Selling
VOR	VOR BIOPHARMA INC	United States	$116.72M	68,259,602	87.32%	10.15%	Net Selling	Net Selling
SLRX	SALARIUS PHARMACEUTICALS INC	United States	$2.16M	4,314,433	2.20%	97.80%
ELEV	ELEVATION ONCOLOGY INC	United States	$179.21M	54,638,262	47.31%	21.57%	Net Selling	Net Selling
CDXS	CODEXIS INC	United States	$255.42M	70,557,577	46.84%	53.16%	Net Buying
ATNM	ACTINIUM PHARMACEUTICALS INC	United States	$260.01M	29,783,451	15.63%	84.37%
BIO	BIO-RAD LABORATORIES INC	United States	$8.04B	28,524,797	22.79%	77.21%	Net Buying	Net Selling
SLDB	SOLID BIOSCIENCES INC	United States	$392.29M	37,756,877	21.64%	78.36%	Net Buying	Net Selling
TNYA	TENAYA THERAPEUTICS INC	United States	$329.77M	78,516,142	55.16%	44.84%	Net Buying	Net Selling
ALLK	ALLAKOS INC	United States	$106.25M	88,544,474	46.03%	53.97%	Net Selling	Net Selling
XYLO	XYLO TECHNOLOGIES LTD	Israel	$3.36M	27,989,465	0.02%	0.00%
FLGC	FLORA GROWTH CORP	United States	$12.31M	8,984,836	12.53%	81.49%	Net Buying	Net Buying
BBLG	BONE BIOLOGICS CORP	United States	$1.03M	534,238	0.02%	99.98%	Net Buying
BCAB	BIOATLA INC	United States	$130.34M	48,096,717	56.14%	33.68%	Net Buying	Net Selling
CYCC	CYCLACEL PHARMACEUTICALS INC	United States	$2.99M	1,318,257	1.23%	98.77%	Net Buying
VIRI	VIRIOS THERAPEUTICS INC	United States	$6.84M	19,257,937	4.47%	5.34%	Net Buying
PXDT	PIXIE DUST TECHNOLOGIES INC	Japan	$35.73M	14,702,267	0.39%	0.00%
RAPT	RAPT THERAPEUTICS INC	United States	$151.13M	34,903,476	66.33%	33.67%	Net Selling
GTBP	GT BIOPHARMA INC	United States	$4.59M	1,380,633	73.85%	26.15%	Net Buying
PDSB	PDS BIOTECHNOLOGY CORP	United States	$128.74M	36,679,275	22.71%	31.97%
CERT	CERTARA INC	United States	$2.73B	160,841,451	73.33%	26.67%	Net Selling	Net Selling
SHLT	SHL TELEMEDICINE LTD	Israel	$68.05M	16,392,754	3.86%	0.00%
CAPR	CAPRICOR THERAPEUTICS INC	United States	$166.42M	31,399,667	11.23%	88.77%	Net Buying	Net Buying
GRI	GRI BIO INC	United States	$1.55M	3,774,488	5.76%	72.87%
WVE	WAVE LIFE SCIENCES LTD	Singapore	$688.23M	122,460,160	61.18%	38.82%	Net Buying	Net Selling
BMEA	BIOMEA FUSION INC	United States	$382.81M	35,944,584	61.83%	38.17%	Net Selling
TIL	INSTIL BIO INC	United States	$75.32M	6,503,913	4.92%	95.08%
BVS	BIOVENTUS INC	United States	$429.92M	79,614,354	29.53%	70.47%	Net Buying	Net Selling
INGN	INOGEN INC	United States	$199.46M	23,577,109	72.68%	27.32%	Net Selling	Net Selling
GLSI	GREENWICH LIFESCIENCES INC	United States	$177.08M	12,878,409	4.02%	95.98%	Net Buying	Net Buying
NOTV	INOTIV INC	United States	$96.97M	25,790,680	18.17%	43.71%	Net Buying
OPT	OPTHEA LTD	Australia	$211.39M	467,159,374	1.53%	0.00%
CMND	CLEARMIND MEDICINE INC	Canada (Federal Level)	$4.44M	3,169,570	2.92%	0.00%
DYNT	DYNATRONICS CORP	United States	$2.51M	5,308,519	2.90%	97.10%	Net Buying
BLTE	BELITE BIO INC	United States	$1.23B	29,149,444	0.53%	0.00%
CTNM	CONTINEUM THERAPEUTICS INC	United States	N/A	27,055,790	0.00%	9.96%
SRRK	SCHOLAR ROCK HOLDING CORP	United States	$1.06B	79,754,065	60.56%	39.44%	Net Buying	Net Selling
AWH	ASPIRA WOMEN's HEALTH INC	United States	$36.66M	12,344,104	0.84%	99.16%	Net Buying
HUGE	FSD PHARMA INC	Canada	$13.39M	39,376,795	1.24%	0.00%
GNTA	GENENTA SCIENCE SPA	Italy	$56.47M	18,216,958	2.53%	0.00%
LCTX	LINEAGE CELL THERAPEUTICS INC	United States	$220.89M	188,798,145	34.36%	65.64%	Net Buying
INSM	INSMED INC	United States	$3.86B	148,604,548	79.99%	20.01%	Net Selling	Net Buying
PRLD	PRELUDE THERAPEUTICS INC	United States	$204.89M	54,929,567	52.43%	47.57%	Net Buying	Net Selling
ALXO	ALX ONCOLOGY HOLDINGS INC	United States	$844.54M	52,100,107	75.63%	24.37%	Net Selling	Net Selling
THMO	THERMOGENESIS HOLDINGS INC	United States	$5.33M	7,952,780	0.26%	99.74%	Net Buying	Net Buying
ONCY	ONCOLYTICS BIOTECH INC	Canada	$88.24M	75,419,768	6.82%	0.00%
TLIS	TALIS BIOMEDICAL CORP	United States	$35.46M	3,813,067	20.89%	76.74%
PEPG	PEPGEN INC	United States	$453.29M	32,354,495	50.08%	18.34%	Net Buying
TIVC	TIVIC HEALTH SYSTEMS INC	United States	$740.38k	1,466,092	2.28%	97.72%
RLYB	RALLYBIO CORP	United States	$75.85M	41,449,297	43.27%	56.73%
OMCL	OMNICELL INC	United States	$1.38B	45,923,492	95.18%	4.82%	Net Selling	Net Selling
DYN	DYNE THERAPEUTICS INC	United States	$2.27B	87,382,638	65.80%	34.20%	Net Selling	Net Selling
ADVM	ADVERUM BIOTECHNOLOGIES INC	United States	$193.04M	20,756,850	72.30%	27.70%	Net Buying
RPHM	RENEO PHARMACEUTICALS INC	United States	$60.49M	33,420,808	61.78%	38.22%	Net Selling
QNRX	QUOIN PHARMACEUTICALS LTD	Israel	$3.08M	3,979,970	0.00%	100.00%
APGE	APOGEE THERAPEUTICS INC	United States	$2.70B	50,655,671	82.46%	11.78%	Net Buying
APM	APTORUM GROUP LTD	China	$25.86M	5,181,697	0.85%	40.28%
MGRX	MANGOCEUTICALS INC	United States	$6.09M	23,619,500	0.45%	41.07%
INZY	INOZYME PHARMA INC	United States	$280.82M	61,855,509	54.64%	45.36%	Net Buying	Net Selling
ARAY	ACCURAY INC	United States	$160.78M	99,244,173	60.78%	39.22%	Net Selling	Net Selling
AMRN	AMARIN CORP PLC	Ireland	$350.47M	410,868,659	22.85%	15.40%	Net Selling
GNPX	GENPREX INC	United States	$4.43M	1,910,441	48.09%	51.91%	Net Selling	Net Selling
ASRT	ASSERTIO HOLDINGS INC	United States	$91.32M	95,124,605	48.89%	20.35%	Net Selling	Net Selling
INDV	INDIVIOR PLC	United Kingdom	$2.42B	136,526,357	47.21%	0.00%
ENLV	ENLIVEX THERAPEUTICS LTD	Israel	$27.90M	18,598,555	1.01%	77.27%
ENVB	ENVERIC BIOSCIENCES INC	United States	$6.49M	7,294,005	6.71%	5.99%	Net Buying
ZIMV	ZIMVIE INC	United States	$454.36M	27,288,700	86.28%	13.72%	Net Selling	Net Selling
SLN	SILENCE THERAPEUTICS PLC	United Kingdom	$839.41M	118,846,966	17.28%	0.00%
MDXH	MDXHEALTH SA	Belgium	$7.56M	27,288,093	11.79%	88.21%
EBS	EMERGENT BIOSOLUTIONS INC	United States	$227.95M	52,401,850	45.68%	54.32%	Net Selling	Net Selling
ONCT	ONCTERNAL THERAPEUTICS INC	United States	$24.21M	2,959,645	13.07%	86.93%	Net Selling	Net Buying
OFIX	ORTHOFIX MEDICAL INC	United States	$549.43M	37,529,256	87.71%	12.29%	Net Buying	Net Selling
XNCR	XENCOR INC	United States	$1.39B	61,662,550	66.74%	33.26%	Net Buying	Net Selling
ICUI	ICU MEDICAL INC	United States	$2.61B	24,365,990	68.28%	31.72%	Net Selling	Net Selling
GRTS	GRITSTONE BIO INC	United States	$85.12M	108,569,374	38.76%	20.10%	Net Buying
SYRA	SYRA HEALTH CORP	United States	$9.25M	6,421,632	1.06%	10.80%	Net Buying
BLCO	BAUSCH & LOMB CORP	Canada	$5.42B	351,482,100	11.05%	88.95%	Net Selling	Net Selling
SYRE	SPYRE THERAPEUTICS INC	United States	$1.49B	40,283,414	52.09%	47.91%	Net Buying	Net Buying
MRVI	MARAVAI LIFESCIENCES HOLDINGS INC	United States	$2.64B	251,924,898	35.06%	64.94%	Net Selling	Net Selling
PIRS	PIERIS PHARMACEUTICALS INC	United States	$13.79M	1,236,688	89.20%	10.80%	Net Buying
FHTX	FOGHORN THERAPEUTICS INC	United States	$236.78M	42,585,616	61.51%	18.76%	Net Selling	Net Selling
INFU	INFUSYSTEM HOLDINGS INC	United States	$155.03M	21,295,254	26.63%	73.37%	Net Selling	Net Selling
GEHC	GE HEALTHCARE TECHNOLOGIES INC	United States	$38.07B	456,465,369	81.42%	7.45%	Net Selling	Net Selling
BDRX	BIODEXA PHARMACEUTICALS PLC	United Kingdom	$4.72M	1,699,804,122	0.00%	0.00%
VNRX	VOLITIONRX LTD	United States	$68.03M	82,068,442	7.76%	40.12%	Net Buying	Net Selling
COSM	COSMOS HEALTH INC	United States	$9.25M	13,404,204	14.67%	11.88%	Net Buying	Net Buying
CRDL	CARDIOL THERAPEUTICS INC	Canada	$139.85M	65,352,279	10.58%	0.00%
CARM	CARISMA THERAPEUTICS INC	United States	$61.48M	41,542,744	21.66%	74.42%
TSVT	2SEVENTY BIO INC	United States	$225.16M	51,405,419	65.20%	34.80%	Net Buying	Net Buying

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	680	-1.62%	-2.51%	-3.52%	-21.05%	6.42x	5.91x	+20.97%	+3.56%	-33.88%	+84.90%	Strong Buy
Diagnostics & Research	66	+5.11%	+7.27%	+4.18%	+9.23%	37.39x	4.36x	-13.51%	+6.44%	+11.47%	+3.98%	Buy
Drug Manufacturers - General	17	-0.53%	+1.82%	+3.59%	+14.38%	31.93x	6.33x	+33.48%	+8.06%	+14.18%	+12.79%	Buy
Drug Manufacturers - Specialty & Generic	90	-0.72%	-1.27%	+0.66%	-6.21%	-3.15x	2.17x	+11.81%	+3.11%	+6.07%	+34.14%	Buy
Healthcare Plans	12	+0.39%	+3.48%	+3.54%	+2.41%	25.16x	3.02x	+15.17%	+4.73%	+11.77%	+13.27%	Buy
Health Information Services	59	-1.02%	-2.32%	-6.09%	-23.97%	12.79x	3.34x	+7.06%	+2.44%	+6.04%	+33.12%	Buy
Medical Care Facilities	51	+0.10%	+3.37%	+1.26%	+10.73%	39.75x	4.47x	-95.44%	+6.74%	+14.01%	+14.51%	Buy
Medical Devices	153	-0.47%	-1.92%	-4.16%	-14.44%	29.79x	3.92x	+7.18%	+5.22%	+7.62%	+21.81%	Buy
Medical Distribution	9	+0.59%	+3.79%	-0.11%	+28.86%	26.83x	110.00x	-10.56%	+3.43%	+19.55%	+9.31%	Buy
Medical Instruments & Supplies	56	+0.54%	+1.52%	-0.53%	-8.80%	58.36x	3.57x	+11.29%	+7.72%	+10.10%	+19.62%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in May 2024?

According to Zen Score, the 3 best healthcare stocks to buy right now are:

1. Cross Country Healthcare (NASDAQ:CCRN)

Cross Country Healthcare (NASDAQ:CCRN) is the top healthcare stock with a Zen Score of 70, which is 45 points higher than the healthcare sector average of 25. It passed 22 out of 33 due diligence checks and has strong fundamentals. Cross Country Healthcare has seen its stock lose -38.53% over the past year, underperforming other healthcare stocks by -31 percentage points.

Cross Country Healthcare has an average 1 year price target of $19.50, an upside of 30.61% from Cross Country Healthcare's current stock price of $14.93.

Cross Country Healthcare stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Cross Country Healthcare, 25% have issued a Strong Buy rating, 25% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Semler Scientific (NASDAQ:SMLR)

Semler Scientific (NASDAQ:SMLR) is the second best healthcare stock with a Zen Score of 68, which is 43 points higher than the healthcare sector average of 25. It passed 21 out of 33 due diligence checks and has strong fundamentals. Semler Scientific has seen its stock lose -5.48% over the past year, overperforming other healthcare stocks by 2 percentage points.

3. Corcept Therapeutics (NASDAQ:CORT)

Corcept Therapeutics (NASDAQ:CORT) is the third best healthcare stock with a Zen Score of 67, which is 42 points higher than the healthcare sector average of 25. It passed 22 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 12.67% over the past year, overperforming other healthcare stocks by 20 percentage points.

Corcept Therapeutics has an average 1 year price target of $40.67, an upside of 50.4% from Corcept Therapeutics's current stock price of $27.04.

Corcept Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Corcept Therapeutics, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 72 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Mei Pharma (NASDAQ:MEIP)

Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 57.95%, which is 55 percentage points higher than the healthcare sector average of 2.88%.

Mei Pharma's dividend payout ratio of 44.6% indicates that its high dividend yield is sustainable for the long-term.

2. Siga Technologies (NASDAQ:SIGA)

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 14.08%, which is 11 percentage points higher than the healthcare sector average of 2.88%.

Siga Technologies's dividend payout ratio of 95.5% indicates that its high dividend yield might not be sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 8.36%, which is 5 percentage points higher than the healthcare sector average of 2.88%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 148.8% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.3% in the last day, and up 0.86% over the last week. Novavax was the among the top gainers in the healthcare sector, gaining 98.66% yesterday.

Novavax shares are trading higher after the company and Sanofi announced a co-exclusive licensing agreement to commercialize a COVID-19 vaccine and develop COVID-influenza combination vaccines.

What are the most undervalued healthcare stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare stocks right now are:

1. Inmode (NASDAQ:INMD)

Inmode (NASDAQ:INMD) is the most undervalued healthcare stock based on WallStreetZen's Valuation Score. Inmode has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Inmode's stock has dropped -47.49% in the past year. It has underperformed other stocks in the healthcare sector by -40 percentage points.

2. Pacira Biosciences (NASDAQ:PCRX)

Pacira Biosciences (NASDAQ:PCRX) is the second most undervalued healthcare stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -31.41% in the past year. It has underperformed other stocks in the healthcare sector by -24 percentage points.

3. Semler Scientific (NASDAQ:SMLR)

Semler Scientific (NASDAQ:SMLR) is the third most undervalued healthcare stock based on WallStreetZen's Valuation Score. Semler Scientific has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Semler Scientific's stock has dropped -5.48% in the past year. It has overperformed other stocks in the healthcare sector by 2 percentage points.

Are healthcare stocks a good buy now?

48.62% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 35.12% over the next year.

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 26.88x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.